• SENSEX 76,755.05
    -715.06 (--0.92%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Bharti Airtel
    1,956.00 2,174.70(%)
  • Bluestone Jewel
    872.60 872.60(%)
  • Anthem Bioscienc
    735.10 579.45(%)
  • IndusInd Bank
    1,077.80 1,077.80(%)
  • M & M Fin. Serv.
    384.55 412.30(%)
  • Data Pattern
    4,800.00 4,955.00(%)
  • TVS Motor Co.
    3,965.00 3,970.00(%)
  • Cummins India
    5,635.00 6,142.80(%)
  • Bajaj Auto
    11,025.00 11,025.00(%)
  • SBI Funds Mgt.
    582.55 582.55(%)
  • Bandhan Bank
    169.65 134.30(%)
  • HDFC Bank
    750.25 726.75(%)
  • Kalyan Jewellers
    601.25 617.30(%)
  • Eternal
    275.70 212.55(%)
  • Reliance Industries
    1,284.00 1,253.65(%)
  • Bajaj Finance
    1,056.30 788.40(%)
  • Dixon Technolog.
    13,650.00 9,605.05(%)
  • Himadri Special
    760.20 420.00(%)
  • Titan Company
    4,730.10 4,730.10(%)
  • Nestle India
    1,509.75 1,509.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fredun Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5269.0
  • ISIN : INE194R01017
885.75 -31 (-3.37%)
  • As on 23 Jul 2026 (EOD)

  • Today’s Low

    865.00

  • Today’s High

    925.00

  • Open

    905.00

  • Perv Close

    916.60

  • 52W Low

    299.63

  • 52W High

    999.00

Key Indicators

  • P/E(TTM)

    44.11

  • Mar.Cap (₹Cr.)

    1,464.86

  • Div & Yield %

    0.03

  • Book Value(₹)

    163.14

  • Debt-Equity Ratio

    -3.37

  • AGM Date

    22-Jul-2026

  • EPS

    20.08

  • P/E Ratio

    44.11

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1,464.86

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.54

  • BV (₹)

    163.10

  • Sales( ₹ in Cr.)

    635.47

  • NP (in Cr.)

    33.21

  • NP Var(%)

    60.0

  • Div%

    7.0

  • CPS (₹)

    24.90

  • EPS (₹)

    20.10

  • Traded Value (₹ in Lakhs)

    1,464.86

  • 52 Week High

    999.00

  • 52 Week Low

    299.63

  • Price BSE

    886.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    1,464.86

  • P/C Ratio

    35.60

  • P/E Ratio

    44.10

  • Price Vs.BV

    20.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 635.47 453.82 348.16 274.68 224.46 133.89
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 635.47 453.82 348.16 274.68 224.46 133.89
Other Income 3.66 2.45 0.92 1.82 1.63 1.40
Stock Adjustments 31.69 -6.05 22.44 37.72 0.01 -1.17
Total Income 670.82 450.22 371.52 314.22 226.10 134.12
EXPENDITURE :            
Raw Materials 480.76 321.89 282.42 245.57 176.45 100.60
Power and Fuel Cost 5.35 4.79 4.03 3.17 3.68 3.32
Employee Cost 32.94 22.23 12.50 11.54 10.66 8.66
Other Manufacturing Expenses 17.66 17.17 11.68 8.08 6.59 3.87
Selling and Administration Expenses 36.72 26.42 20.77 14.55 12.76 7.80
Miscellaneous Expenses 2.59 2.63 1.22 1.71 0.46 0.28
Employee Benefit Expenses 32.94 22.23 12.50 11.54 10.66 8.66
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 576.02 395.12 332.61 284.62 210.60 124.54
Operating Profit 94.80 55.10 38.90 29.60 15.50 9.58
Interest 39.30 22.38 13.65 9.28 4.74 4.37
Gross Profit 55.50 32.72 25.25 20.32 10.76 5.21
Depreciation 7.91 4.45 3.80 2.81 2.16 2.00
Profit Before Tax 47.59 28.27 21.45 17.51 8.60 3.21
Current Tax 12.31 7.12 5.54 4.29 2.21 0.76
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.06 0.35 0.29 2.41 0.05 0.44
Reported Net Profit 33.21 20.81 15.62 10.81 6.34 2.01
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 33.21 20.81 15.62 10.81 6.34 2.01
Adjustment below Net Profit 0.17 -20.81 -0.07 0.05 0.02 0.00
P & L Balance brought forward 63.91 63.91 28.55 18.00 11.93 10.18
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.33 0.00 0.33 0.31 0.28 0.27
P & L Balance carried down 96.95 63.91 43.77 28.55 18.00 11.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 7.00 7.00 7.00 7.00 7.00 7.00
Dividend Per Share(Rs) 0.70 0.70 0.70 0.70 0.70 0.70
Earnings Per Share-Unit Curr 60.68 44.07 33.25 23.84 14.29 5.05
Earnings Per Share(Adj)-Unit Curr 20.23 14.69 11.08 7.95 4.76 1.68
Book Value 483.87 299.47 255.15 194.27 153.07 107.96
Book Value(Adj)-Unit Curr 161.29 99.82 85.05 64.76 51.02 35.99

Shareholding Pattern

  • Promoter Group

    44.57%

  • Public Share Holding

    55.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 7,371,159 44.57 7,371,159 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,371,159 44.57 7,371,159 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 225,000 1.36 225,000 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 175,980 1.06 175,980 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 260,592 1.58 260,592 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 661,572 4.00 661,572 9
2] Non Institution
Bodies Corporate 623,721 3.77 581,421 102
Clearing Members 2,853 0.02 2,853 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 371,886 2.25 371,886 290
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 213,078 1.29 213,078 189
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,634,554 21.98 3,634,554 53
Individuals holding nominal share capital up to Rs. 1 lakh 3,579,249 21.64 3,387,639 8,926
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,505,339 51.43 8,262,129 9,586
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,538,070 100.00 16,294,860 9,598

Company Background

Fredun Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Fredun Pharmaceuticals Ltd
  • BSE Code : 5269.0
  • ISIN : INE194R01017

  • Incorporation Year

    1987

  • Registered Office

    26 Manoj Industrial Premises
    G D Ambedkar Marg Wadala, Mumbai,
    Maharashtra-400031

  • Telephone

    91-22-40318111

  • FAX

  • Chairman

    Daulat N Medhora

  • Managing Director

    Fredun N Medhora

  • Company Secretary

    Vaishnavi Rajkamal Sahu

  • Auditor

    R.H. Nisar & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Fredun Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Fredun Pharma 885.75 639.12 635.47 44.11 21.28
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Fermenta Biotec. 420.85 442.21 430.53 19.27 17.61
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77